Medical Condition News

RSS

Ranbaxy announces launch of Letrozole Tablets in UK, Romania and France

Ranbaxy Laboratories Limited today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK, USD 95 Mn in France and USD 5.5 Mn in Romania.

25 Jul 2011

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrier® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).

25 Jul 2011

Biogen Idec's FAMPYRA receives EU conditional approval for treating functional impairment in MS

Biogen Idec announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis who have walking disability.

25 Jul 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.

From Baxter International Inc. 25 Jul 2011

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.

25 Jul 2011

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

BioDelivery Sciences International, Inc. announced today that the last patient has completed the randomized portion of its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain, signifying completion of the trial.

25 Jul 2011

Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine

VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.

25 Jul 2011

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

25 Jul 2011

Novalis Tx system for treatment of cancer goes into service today

A treatment system called the Novalis Tx has gone into service today, which has the ability to destroy cancerous cells virtually anywhere in the body in a single, 20-minute session, without the need for a single cut of the scalpel.

25 Jul 2011

R-Tech Ueno announces protocol amendment of RK-023 Phase I trial for eyelash hypotrichosis

R-Tech Ueno is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes.

25 Jul 2011

Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes

Kaiser Permanente Northern California patients who obtained new statin prescriptions via a mail-order pharmacy achieved better cholesterol control in the first 3-15 months following the initiation of therapy -- compared to those patients who only obtained their statin prescription from their local Kaiser Permanente Northern California pharmacy.

25 Jul 2011

Study explores factors for misuse of prescription opioid in young injection drug users

A new study by researchers at Drexel University's School of Public Health suggests that abuse of prescription painkillers may be an important gateway to the use of injected drugs such as heroin, among people with a history of using both types of drugs.

25 Jul 2011

Health Canada approves Valeant's NDA for Sublinox to treat insomnia

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant Canada Limited, has received notice that the New Drug Submission for Sublinox has been approved from the Canadian regulatory authority Health Canada.

25 Jul 2011

Children with ADHD may face increased risk of pedestrian injury

Children with attention deficit/hyperactivity disorder (ADHD) are at increased risk of being hit by a vehicle when crossing a street, according to new research from the University of Alabama at Birmingham.

25 Jul 2011

Specific yeast protein can promote spontaneous prion formation

It's a chicken and egg question. Where do the infectious protein particles called prions come from? Essentially clumps of misfolded proteins, prions cause neurodegenerative disorders, such as mad cow/Creutzfeld-Jakob disease, in humans and animals.

25 Jul 2011

Eating location, food source impact daily energy intake for children

As childhood obesity rises and the American diet shifts towards increasing consumption of foods eaten or prepared outside of the home, concerns about the nutritional quality and the total consumption of such foods are also increasing.

25 Jul 2011

Aspen Dental to inaugurate new office in Davenport, Iowa

Patients looking for a dentist in Davenport, Iowa now have a new dental care provider option with the opening of a new Aspen Dental office this month. The new practice, which opens on July 28 at 5270 Elmore Avenue, will provide dental services that range from dentures and preventive care to general dentistry and restoration.

25 Jul 2011

PNH patients applaud pan-Canadian approach to providing equitable access to Soliris

The Canadian Association of PNH Patients applauds governments across Canada for their landmark agreement to provide public access to Soliris (eculizumab), a life-saving treatment for the ultra-rare blood disease known as paroxysmal nocturnal haemoglobinuria.

25 Jul 2011

GlaxoSmithKline files suit against Watson over generic JALYN

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market dutasteride and tamsulosin hydrochloride capsules.

25 Jul 2011

MHCC, U of C partner to evaluate 'The Mind Course' for medical students

The Mental Health Commission of Canada (MHCC) has partnered with the University of Calgary's Faculty of Medicine to evaluate a special course for second year medical students which aims to reduce the prejudice and discrimination associated with mental illness.

25 Jul 2011

Medical Condition News

Ranbaxy announces launch of Letrozole Tablets in UK, Romania and France

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

Biogen Idec's FAMPYRA receives EU conditional approval for treating functional impairment in MS

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

Mayo Clinic trial to evaluate folate receptor alpha-targeted breast/ovarian cancer vaccine

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Novalis Tx system for treatment of cancer goes into service today

R-Tech Ueno announces protocol amendment of RK-023 Phase I trial for eyelash hypotrichosis

Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes

Study explores factors for misuse of prescription opioid in young injection drug users

Health Canada approves Valeant's NDA for Sublinox to treat insomnia

Children with ADHD may face increased risk of pedestrian injury

Specific yeast protein can promote spontaneous prion formation

Eating location, food source impact daily energy intake for children

Aspen Dental to inaugurate new office in Davenport, Iowa

PNH patients applaud pan-Canadian approach to providing equitable access to Soliris

GlaxoSmithKline files suit against Watson over generic JALYN

MHCC, U of C partner to evaluate 'The Mind Course' for medical students

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News